◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TAK

Takeda Pharmaceutical Co Ltd ADR (TAK) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-09-10

Takeda Pharmaceutical Co Ltd ADR (TAK) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Chuo, Japan with about 47,029 employees. Its market capitalization is roughly $60 billion. In the fiscal year ended 2026-03-31, TAK reported JPY 4.78T in revenue and JPY 203.3B in net income.

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Interactive charts & full statements → Open the TAK valuation workbench →

TAK Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Revenue	JPY 4.66T	JPY 4.78T	JPY 4.58T	JPY 4.26T	JPY 4.03T	JPY 3.57T	JPY 3.20T	JPY 3.29T	JPY 2.10T	JPY 1.77T	JPY 1.73T	JPY 1.81T	JPY 1.78T	JPY 1.69T	JPY 1.56T	JPY 1.51T	JPY 1.42T	JPY 1.47T	JPY 1.54T	JPY 1.37T	JPY 1.31T
Gross Profit	JPY 2.75T	JPY 2.44T	JPY 3.00T	JPY 2.83T	JPY 2.78T	JPY 2.46T	JPY 2.20T	JPY 2.20T	JPY 1.44T	JPY 1.27T	JPY 1.17T	JPY 1.27T	JPY 1.26T	JPY 1.20T	JPY 1.11T	JPY 1.08T	JPY 1.10T	JPY 1.18T	JPY 1.25T	JPY 1.10T	JPY 1.03T
Gross Margin %	59.0%	51.1%	65.5%	66.4%	69.1%	69.0%	68.9%	66.9%	68.5%	72.0%	67.7%	70.4%	70.7%	71.0%	71.3%	71.3%	77.6%	80.5%	81.2%	79.7%	78.6%
Operating Income (EBIT)	JPY 512.0B	JPY 573.0B	JPY 342.6B	JPY 214.1B	JPY 490.5B	JPY 460.8B	JPY 509.3B	JPY 100.4B	JPY 205.0B	JPY 241.8B	JPY 155.9B	JPY 130.8B	(JPY 129.3B)	JPY 139.3B	JPY 122.5B	JPY 265.0B	JPY 367.1B	JPY 420.2B	JPY 306.5B	JPY 423.1B	JPY 458.5B
Operating Margin %	11.0%	12.0%	7.5%	5.0%	12.2%	12.9%	15.9%	3.0%	9.8%	13.7%	9.0%	7.2%	-7.3%	8.2%	7.9%	17.6%	25.9%	28.7%	19.9%	30.8%	35.1%
Net Income	JPY 182.1B	JPY 203.3B	JPY 107.9B	JPY 144.1B	JPY 317.0B	JPY 230.1B	JPY 376.0B	JPY 44.2B	JPY 109.1B	JPY 186.9B	JPY 114.9B	JPY 80.2B	(JPY 145.8B)	JPY 106.7B	JPY 131.2B	JPY 124.2B	JPY 247.9B	JPY 297.7B	JPY 234.4B	JPY 355.5B	JPY 335.8B
Net Margin %	3.9%	4.3%	2.4%	3.4%	7.9%	6.5%	11.8%	1.3%	5.2%	10.6%	6.6%	4.4%	-8.2%	6.3%	8.4%	8.2%	17.5%	20.3%	15.2%	25.9%	25.7%
EBITDA	JPY 1.27T	JPY 1.42T	JPY 1.21T	JPY 1.14T	JPY 1.28T	JPY 1.18T	JPY 983.7B	JPY 671.9B	JPY 464.2B	JPY 360.0B	JPY 296.9B	JPY 349.9B	JPY 57.3B	JPY 368.2B	JPY 351.2B	JPY 404.6B	JPY 479.6B	JPY 532.1B	JPY 518.2B	JPY 608.9B	JPY 654.4B
Earnings Per Share (EPS)	JPY 56.53	JPY 63.43	JPY 33.61	JPY 45.58	JPY 100.97	JPY 72.93	JPY 119.48	JPY 14.12	JPY 56.43	JPY 118.78	JPY 73.13	JPY 50.86	JPY -92.69	JPY 67.48	JPY 83.10	JPY 78.63	JPY 156.97	JPY 188.57	JPY 144.90	JPY 209.48	JPY 193.00
Shares Outstanding (M)	3,209M	3,206M	3,211M	3,161M	3,140M	3,154M	3,147M	3,132M	1,934M	1,573M	1,572M	1,576M	1,573M	1,581M	1,579M	1,579M	1,579M	1,579M	1,618M	1,697M	1,740M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TAK Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	JPY 1.22T	JPY 1.11T	JPY 1.21T	JPY 1.11T	JPY 1.11T	JPY 1.05T	JPY 1.14T	JPY 1.18T
Gross Profit	JPY 813.2B	JPY 543.8B	JPY 660.3B	JPY 732.7B	JPY 722.0B	JPY 671.3B	JPY 727.2B	JPY 781.7B
Gross Margin %	66.7%	48.8%	54.4%	65.8%	65.2%	63.7%	63.6%	66.5%
Operating Income (EBIT)	JPY 201.4B	JPY 47.5B	JPY 194.1B	JPY 69.0B	JPY 184.6B	(JPY 74.9B)	JPY 66.9B	JPY 184.2B
Operating Margin %	16.5%	4.3%	16.0%	6.2%	16.7%	-7.1%	5.9%	15.7%
Net Income	JPY 113.2B	(JPY 24.8B)	JPY 105.5B	(JPY 11.8B)	JPY 124.2B	(JPY 103.2B)	JPY 23.8B	JPY 92.0B
Net Margin %	9.3%	-2.2%	8.7%	-1.1%	11.2%	-9.8%	2.1%	7.8%
EBITDA	JPY 337.5B	JPY 157.9B	JPY 456.2B	JPY 316.5B	JPY 439.4B	JPY 181.3B	JPY 193.0B	JPY 380.3B
Earnings Per Share (EPS)	JPY 35.27	JPY -7.93	JPY 32.92	JPY -3.74	JPY 39.11	JPY -32.63	JPY 7.50	JPY 28.59
Shares Outstanding (M)	3,209M	3,125M	3,205M	3,155M	3,176M	3,163M	3,170M	3,220M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TAK Free Cash Flow History

Cash flow	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Cash from Operations (CFO)	JPY 953.6B	JPY 1.04T	JPY 1.06T	JPY 716.3B	JPY 977.2B	JPY 1.12T	JPY 1.01T	JPY 669.8B	JPY 328.5B	JPY 377.9B	JPY 261.4B	JPY 25.5B	JPY 182.5B	JPY 148.7B	JPY 332.6B	JPY 336.6B	JPY 326.9B	JPY 381.2B	JPY 326.3B	JPY 292.5B	JPY 209.3B
Capital Expenditures (CapEx)	JPY 393.4B	JPY 414.7B	JPY 379.6B	JPY 480.7B	JPY 633.7B	JPY 186.0B	JPY 236.5B	JPY 217.7B	JPY 134.1B	JPY 128.3B	JPY 112.0B	JPY 84.9B	JPY 108.7B	JPY 78.5B	JPY 112.3B	JPY 71.0B	JPY 124.2B	JPY 87.0B	JPY 39.5B	JPY 32.6B	JPY 29.2B
Free Cash Flow (FCF)	JPY 560.2B	JPY 626.8B	JPY 677.6B	JPY 235.6B	JPY 343.5B	JPY 937.1B	JPY 774.5B	JPY 452.0B	JPY 194.4B	JPY 249.6B	JPY 149.3B	(JPY 59.4B)	JPY 73.8B	JPY 70.2B	JPY 220.3B	JPY 265.5B	JPY 202.8B	JPY 294.2B	JPY 286.8B	JPY 259.9B	JPY 180.1B
FCF Margin %	12.0%	13.1%	14.8%	5.5%	8.5%	26.3%	24.2%	13.7%	9.3%	14.1%	8.6%	-3.3%	4.2%	4.2%	14.1%	17.6%	14.3%	20.1%	18.6%	18.9%	13.8%
Dividends Paid	JPY 316.7B	JPY 311.9B	JPY 302.5B	JPY 287.2B	JPY 279.4B	JPY 283.7B	JPY 283.4B	JPY 282.6B	JPY 143.0B	JPY 141.9B	JPY 141.7B	JPY 141.5B	JPY 141.6B	JPY 142.1B	JPY 142.1B	JPY 142.0B	JPY 142.1B	JPY 143.6B	JPY 142.4B	JPY 129.2B	JPY 98.8B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TAK Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	JPY 127.6B	JPY 74.5B	JPY 373.3B	JPY 378.2B	JPY 215.4B	JPY 222.2B	JPY 383.8B	JPY 281.0B
Capital Expenditures (CapEx)	JPY 53.8B	JPY 64.4B	JPY 222.4B	JPY 52.8B	JPY 75.1B	JPY 92.7B	JPY 56.7B	JPY 92.5B
Free Cash Flow (FCF)	JPY 73.8B	JPY 10.1B	JPY 150.9B	JPY 325.4B	JPY 140.4B	JPY 129.4B	JPY 327.1B	JPY 188.5B
FCF Margin %	6.0%	0.9%	12.4%	29.2%	12.7%	12.3%	28.6%	16.0%
Dividends Paid	JPY 150.1B	JPY 8.8B	JPY 149.0B	JPY 8.8B	JPY 145.3B	JPY 9.7B	JPY 145.5B	JPY 9.2B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TAK Balance Sheet History

Balance sheet	2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Assets	JPY 15.66T	JPY 15.52T	JPY 14.25T	JPY 15.11T	JPY 13.96T	JPY 13.18T	JPY 12.91T	JPY 12.82T	JPY 13.87T	JPY 4.11T	JPY 4.36T	JPY 3.82T	JPY 4.30T	JPY 4.57T	JPY 3.96T	JPY 3.58T	JPY 2.79T	JPY 2.82T	JPY 2.76T	JPY 2.85T	JPY 3.07T
Cash & Cash Equivalents	JPY 461.0B	JPY 597.6B	JPY 385.1B	JPY 457.8B	JPY 533.5B	JPY 849.7B	JPY 966.2B	JPY 637.6B	JPY 702.1B	JPY 294.5B	JPY 319.5B	JPY 451.4B	JPY 652.1B	JPY 666.0B	JPY 289.6B	JPY 454.2B	JPY 217.9B	JPY 266.5B	JPY 229.5B	JPY 1.61T	JPY 1.65T
Total Liabilities	JPY 8.10T	JPY 7.71T	JPY 7.31T	JPY 7.83T	JPY 7.60T	JPY 7.49T	JPY 7.74T	JPY 8.09T	JPY 8.71T	JPY 2.09T	JPY 2.41T	JPY 1.81T	JPY 2.09T	JPY 2.03T	JPY 1.73T	JPY 1.51T	JPY 649.7B	JPY 658.5B	JPY 706.3B	JPY 526.7B	JPY 611.4B
Total Debt (Short + Long-Term)	JPY 4.94T	JPY 4.88T	JPY 4.52T	JPY 4.84T	JPY 4.38T	JPY 4.35T	JPY 4.64T	JPY 5.09T	JPY 5.75T	JPY 985.7B	JPY 1.14T	JPY 228.5B	JPY 105.2B	JPY 155.4B	JPY 4.5B	JPY 244.7B	JPY 4.1B	JPY 3.3B	JPY 3.2B	JPY 3.4B	JPY 9.6B
Total Shareholders' Equity	JPY 7.56T	JPY 7.81T	JPY 6.94T	JPY 7.27T	JPY 6.35T	JPY 5.68T	JPY 5.17T	JPY 4.72T	JPY 5.16T	JPY 2.00T	JPY 1.89T	JPY 1.95T	JPY 2.14T	JPY 2.47T	JPY 2.16T	JPY 2.01T	JPY 2.09T	JPY 2.12T	JPY 2.01T	JPY 2.28T	JPY 2.42T

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TAK viewer.

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

UTHR · United Therapeutics Corporation — $21 billion
NBIX · Neurocrine Biosciences Inc — $15 billion
ELAN · Elanco Animal Health — $11 billion
RDY · Dr. Reddy’s Laboratories Ltd ADR — $10 billion
ALKS · Alkermes Plc — $7 billion
LNTH · Lantheus Holdings Inc — $7 billion
HIMS · Hims Hers Health Inc — $7 billion
AMRX · Amneal Pharmaceuticals, Inc. Class A Common Stock — $7 billion

← TAJX All “T” companies TAKE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.